Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
clinical trial data
Biotech
Roche heads to FDA as eye disease trials yield mixed data
Roche is forging ahead with plans to seek approval for an eye disease candidate despite missing the primary endpoint in one of its phase 3 trials.
Nick Paul Taylor
Oct 20, 2025 9:28am
Vivace hits high note in midstage mesothelioma trial
Oct 19, 2025 10:30am
Evaxion stock slips on phase 2 cancer vax data
Oct 17, 2025 2:07pm
ESMO: BMS believes ADC data allow it to 'stay ahead' of rivals
Oct 17, 2025 10:30am
Gilead, Arcus keep TIGIT dream alive with 27-month OS data
Oct 13, 2025 7:05am
Moderna posts melanoma data behind decision to say 'I do' to IDO
Oct 13, 2025 5:15am
